Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories.
Pipe S, Sadeghi-Khomami A, Konkle BA, Kitchen S, Negrier C, Liu M, Santagostino E, Willemze A, Abad-Franch L, Knobe K, Seth Chhabra E. Pipe S, et al. Among authors: negrier c. Haemophilia. 2024 Jan;30(1):214-223. doi: 10.1111/hae.14831. Epub 2023 Oct 30. Haemophilia. 2024. PMID: 37902390
New developments in laboratory diagnosis and monitoring.
Kitchen S, Hayward C, Negrier C, Dargaud Y. Kitchen S, et al. Among authors: negrier c. Haemophilia. 2010 Jul;16 Suppl 5:61-6. doi: 10.1111/j.1365-2516.2010.02295.x. Haemophilia. 2010. PMID: 20590858 Review. No abstract available.
Global haemostasis and point of care testing.
Dargaud Y, Sorensen B, Shima M, Hayward C, Srivastava A, Negrier C. Dargaud Y, et al. Among authors: negrier c. Haemophilia. 2012 Jul;18 Suppl 4:81-8. doi: 10.1111/j.1365-2516.2012.02855.x. Haemophilia. 2012. PMID: 22726088
Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
Tiede A, Abdul-Karim F, Carcao M, Persson P, Clausen WHO, Kearney S, Matsushita T, Negrier C, Oldenburg J, Santagostino E, Young G. Tiede A, et al. Among authors: negrier c. Haemophilia. 2017 Jul;23(4):547-555. doi: 10.1111/hae.13191. Epub 2017 Feb 24. Haemophilia. 2017. PMID: 28233381 Clinical Trial.
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.
Oldenburg J, Mahlangu JN, Bujan W, Trask P, Callaghan MU, Young G, Asikanius E, Peyvandi F, Santagostino E, Kruse-Jarres R, Negrier C, Kessler C, Xu J, Windyga J, Shima M, von Mackensen S. Oldenburg J, et al. Among authors: negrier c. Haemophilia. 2019 Jan;25(1):33-44. doi: 10.1111/hae.13618. Epub 2018 Nov 14. Haemophilia. 2019. PMID: 30427582 Free article. Clinical Trial.
289 results